Prestige Consumer Healthcare Inc. (PBH) Institutional Ownership & Insider Trading

318 institutions reported holding Prestige Consumer Healthcare Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 8 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

PBHPrestige Consumer Healthcare Inc.Follow PBH — free

Drug Manufacturers - Specialty & Generic · Healthcare

—

Price chart with a free account

Market cap: 2.3B
P/E TTM: 13.4
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 12 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

318 institutions held —% of the shares. Across filers that reported both quarters, shares held changed +3.4%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	318	54	+3.4%	104	25	111	62
Mar 26	351	52	+2.4%	127	38	114	37
Dec 25	348	52	-3.3%	119	27	125	32
Sep 25	351	51	+0.2%	106	31	125	50
Jun 25	373	52	+0.8%	134	43	94	26
Mar 25	355	51	-1.5%	100	34	135	19
Dec 24	330	52	+2.1%	108	26	89	17
Sep 24	320	51	-2.0%	104	32	91	14

Prestige Consumer Healthcare Inc. — questions

Who owns Prestige Consumer Healthcare Inc. stock?: 318 institutions reported Prestige Consumer Healthcare Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (16.5%), ARIEL INVESTMENTS, LLC (10.3%), VANGUARD PORTFOLIO MANAGEMENT LLC (6.0%).
Are Prestige Consumer Healthcare Inc. insiders buying or selling?: 8 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Prestige Consumer Healthcare Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.